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Abstract
Background: Nuclear grade has been associated with breast DCIS recurrence and progression to invasive carcinoma; 
however, our previous study of a cohort of patients with breast DCIS did not ﬁ  nd such an association with outcome. Fifty 
percent of patients had heterogeneous DCIS with more than one nuclear grade. The aim of the current study was to inves-
tigate the effect of quantitative nuclear features assessed with digital image analysis on ipsilateral DCIS recurrence.
Methods: Hematoxylin and eosin stained slides for a cohort of 80 patients with primary breast DCIS were reviewed and 
two ﬁ  elds with representative grade (or grades) were identiﬁ  ed by a Pathologist and simultaneously used for acquisition of 
digital images for each ﬁ  eld. Van Nuys worst nuclear grade was assigned, as was predominant grade, and heterogeneous 
grading when present. Patients were grouped by heterogeneity of their nuclear grade: Group A: nuclear grade 1 only, nuclear 
grades 1 and 2, or nuclear grade 2 only (32 patients), Group B: nuclear grades 1, 2 and 3, or nuclear grades 2 and 3 (31 patients), 
Group 3: nuclear grade 3 only (17 patients). Nuclear ﬁ  ne structure was assessed by software which captured thirty-nine 
nuclear feature values describing nuclear morphometry, densitometry, and texture. Step-wise forward Cox regressions were 
performed with previous clinical and pathologic factors, and the new image analysis features.
Results: Duplicate measurements were similar for 89.7% to 97.4% of assessed image features. The rate of correct classiﬁ  -
cation of nuclear grading with digital image analysis features was similar in the two ﬁ  elds, and pooled assessment across 
both ﬁ  elds. In the pooled assessment, a discriminant function with one nuclear morphometric and one texture feature was 
signiﬁ  cantly (p = 0.001) associated with nuclear grading, and provided correct jackknifed classiﬁ  cation of a patient’s nuclear 
grade for Group A (78.1%), Group B (48.4%), and Group C (70.6%). The factors signiﬁ  cantly associated with DCIS recur-
rence were those previously found, type of initial presentation (p = 0.03) and amount of parenchymal involvement (p = 0.05), 
along with the morphometry image feature of ellipticity (p = 0.04).
Conclusion: Analysis of nuclear features measured by image cytometry may contribute to the classiﬁ  cation and prognosis 
of breast DCIS patients with more than one nuclear grade.
Keywords: breast ductal carcinoma in situ, nuclear grade, image cytometry, discriminant analysis
Introduction
The proportion of breast cancers currently being diagnosed in the in situ stage (ductal carcinoma in situ, 
DCIS) has been increasing with the increased use of mammographic screening and now accounts for 
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up to about 25% of breast cancers diagnosed in 
some centers. Nuclear grade is a major determinant 
of therapeutic decisions although there is no single 
accepted grading system (Badve et al. 1998; Hol-
land et al. 1994; Leonard and Swain, 2004; Leong 
et al. 2001; Silverstein et al. 1996; Silverstein, 
2000; Sneige et al. 1999; Tavassoli, 1998; van 
Dongen et al. 1992; Wärnberg et al. 2002; Wärn-
berg et al. 1999).
Nuclear grade has been associated with DCIS 
recurrence (Badve et al. 1998; Burstein et al. 2004; 
Lagios et al. 1989) and progression to invasive 
carcinoma (Lagios et al. 1989; Kerilkowske et al. 
2003). Based on such results, nuclear grade has 
been recommended for the primary stratiﬁ  cation 
of DCIS (Schwarz, 1997). However, the associa-
tion between nuclear grade and recurrence of DCIS 
or development of invasive carcinoma is not as 
clear in some studies in which as many as 50% of 
patients are reported to have more than one nuclear 
grade (Miller et al. 2001). In Miller et al. 2001 
attempts were made to reﬂ  ect and evaluate hetero-
geneity by evaluating both most dominant (most 
prominent) grade and worst grade; however, 
nuclear grading was not associated with clinical 
outcome. In this context, a single grade may not 
be sufﬁ  cient to characterize a patient and this may 
affect the medical therapeutic decisions being 
made. It is important to recognize and account for 
heterogeneity of nuclear grade within each patient 
since as many as 50% of patients with DCIS may 
have more than one nuclear grade (Miller et al. 
2001; Goldstein and Murphy, 1996).
It would be advantageous to have a method to 
obtain reliable quantitative data that could be 
objectively analyzed to assist with the classiﬁ  cation 
of patients who have breast DCIS in which more 
than one nuclear grade is present. Computer-aided 
image analysis is such a method. Image analysis 
has been used to extract quantitative nuclear infor-
mation useful for diagnosis of biopsy specimens 
of many tissues, including breast DCIS, and inva-
sive breast (Kerlikowske et al. 2003; Carpenter 
et al. 1985; Dey et al. 2000; Frank et al. 2001; 
Hoque et al. 2001; Mariuzzi et al. 1996; Mommers 
et al. 2001; Susnik et al. 1995; Tuczek et al. 1996; 
Wolberg et al. 1995). However, these previous 
reports did not focus on evaluating information for 
individual nuclei in the classiﬁ  cation of patients 
with mixed nuclear grades. We previously exam-
ined the role of image analysis of individual nuclei 
for the Miller et al. 2001 cohort with respect to the 
development of invasive breast cancer, and found 
that the reproducible, quantitated image analysis 
features were associated with development of 
invasive disease (Chapman et al. 2007) whereas 
nuclear grade was not. In that study, we determined 
that indications for particular image features across 
fields were not consistent when there was 
heterogeneous grading.
The purpose of this study was to determine, if 
after considering clinical and pathologic factors, 
whether nuclear features measured by digital image 
analysis of hematoxylin and eosin stained slides 
would be signiﬁ  cantly associated with DCIS recur-
rence, and therefore could help pathologists clas-
sify patients whose DCIS was more likely to recur. 
The clinical cohort of patients whose DCIS exhib-
ited substantive heterogeneity (Miller et al. 2001) 
was used for these investigations. We restricted the 
examinations to pooled assessments across ﬁ  elds, 
and an overall patient basis, for better per patient 
representation of nuclear features.
Patients and Methods
Patients and specimens
The DCIS patients whose specimens were used in 
this study were a subset of the 124 previously 
described in detail (Miller et al. 2001; Fish et al. 
1998; Chapman et al. 2007). Of the 124, the cohort 
of 88 patients who underwent lumpectomy alone 
were used, as these patients had experienced most 
of the events: 17 of 19 recurrences of DCIS with 
median 5.0 years of follow-up. Of these 88 patients, 
three did not have slides available for assessment 
and for ﬁ  ve patients the hematoxylin and eosin 
(H&E) stained slides resulted in images of poor 
quality, unsuitable for further evaluation. Digital 
images of the slides of the 80 study patients were 
acquired under the supervision of a breast 
pathologist (NM). Worst nuclear grade of 1, 2, or 3, 
by the Van Nuys system (Silverstein et al. 1996; 
Silverstein et al. 1995) was assigned by the pathol-
ogist by viewing the slides directly in a bright ﬁ  eld 
microscope, yielding 1 patient with grade 1, 31 
with grade 2, and 48 with grade 3 DCIS.
The focus for this study was an investigation 
of the effects of heterogeneity on the assessment 
of image analysis features. When more than one 
grade was present, predominant grade, and all 
grades were recorded for each of two representa-
tive ﬁ  elds for each patient. There were 32 patients 
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in Group A, whose DCIS was nuclear grade 1 only 
(1 patient), grades 1 and grade 2 (8 patients), or 
grade 2 only (23 patients); 31 patients in Group B 
with grades 1, 2, and 3 (2 patients), or grades 
2 and 3 (29 patients); and 17 patients in Group C 
with grade 3 only.
Segmentation and preparation 
of image analysis data
As described above, DCIS heterogeneity was 
observed pathologically with H&E slides. Digital 
images of areas of DCIS identiﬁ  ed by the patholo-
gist were captured with a CCD camera, bright ﬁ  eld 
microscope, desktop computer, and NIH-Image 
software, as described in detail in the Appendix. 
The experimental design involved imaging ﬁ  ve 
ducts in one ﬁ  eld, followed by imaging ﬁ  ve ducts 
in a second ﬁ  eld. Those ﬁ  elds demonstrated DCIS 
of the nuclear grade(s) recorded for that patient. 
The ﬁ  elds were present as two separate ﬁ  elds on 
one slide or one ﬁ  eld on each of two slides. Thus, 
ten or more images in different regions of the 
slides(s) were captured for each patient, 20 or more 
nuclei per image were segmented resulting typically 
in 200 nuclei analyzed for each of the 80 patients. 
The focus for these investigations are the two ﬁ  elds 
with about 100 nuclei assessed per ﬁ  eld and the 
pooled data for both ﬁ  elds, to yield an overall 
assessment for a patient. A blank ﬁ  eld was sub-
tracted from each captured image. Images were 
printed and nuclei labeled with an index number to 
avoid duplication. Contrast enhanced images were 
viewed on a 17 inch monitor and enlarged 4:1. 
These changes did not affect the values extracted 
from the saved image. Each nuclear region of inter-
est was segmented by an operator using a computer 
mouse. The operator was blinded to the grade of 
the specimen determined by the pathologist. All 
nuclear images were segmented by a single person 
(DA). The reproducibility of feature values 
extracted by operator guided segmentation is dis-
cussed in the Results section. Some image feature 
calculations and the merging of all nuclear image 
feature data to per ﬁ  eld and per patient attribution 
were accomplished with StatView v 5.01 (Brain 
Power, Calabasas, CA, USA) software.
Image analysis features
For each nucleus, 39 features were determined in 
three categories. (i) Morphometry: area, perimeter, 
ellipse major axis, ellipse minor axis, ellipticity 
(major axis/minor axis), shape form factor (4 X pi 
X area/perimeter squared), and roundness b (4 X 
area/pi X ellipticity squared) (Russ, 1990). (ii) 
Densitometry: mean density, standard deviation of 
density, modal density, minimum density, maxi-
mum density, sum density (mean density X area, 
used instead of I.O.D. of NIH-Image), range 
density. (iii) Markovian texture features (Haralick 
et al. 1973; Pressman, 1976) were calculated from 
the co-occurrence matrix of pixel densities with a 
step size of 2. They were angular second moment, 
contrast, correlation, variance, inverse difference 
moment, sum average, sum variance (corrected 
from Pressman, 1976), difference average, differ-
ence variance, initial entropy, final entropy, 
entropy, sum entropy, difference entropy, coefﬁ  -
cient of variation, peak transition probability, 
diagonal variance, diagonal moment, second 
diagonal moment, product moment, and triangular 
symmetry. Additional texture features, calculated 
from the binned histogram of pixel gray scale 
values, included histogram mean, histogram vari-
ance, histogram skewness, and histogram kurtosis. 
Similar features have previously been used to clas-
sify breast ductal carcinoma in situ specimens 
(Frank et al. 2001; Hoque et al. 2001).
Prognostic factors
The clinical factors recorded on these patients were 
age (in years) and type of presentation (mammo-
graphic, clinically palpable, bloody nipple dis-
charge). The histologic factors previously evaluated 
(Miller et al. 2001) were maximum DCIS size 
(cm), percentage of parenchyma involved with 
DCIS (10%, 10%–50%, 50%), predominant 
architecture (0—cribriform/micropapillary/other, 
1—solid), worst architecture (0—cribriform/
micropapillary/other, 1—solid), nuclear grade [by 
the Van Nuys Classiﬁ  cation system worst (nuclear 
grade 1, 2, 3); also, predominant (nuclear grade 1, 
2, 3)] and heterogeneous nuclear grading (Group A, 
Group B, Group C)], necrosis [none, conﬂ  uent 
(comedo-like)], calciﬁ  cation (none, crystalline/
amorphous), measured margin (zero margin, 
1 mm, 1–5 mm, 5 mm), presence of uninvolved 
intervening duct (not assessable, no, yes), Van 
Nuys Prognostic Index. In addition, 39 nuclear 
image features were determined for about 200 
nuclei per patient.
For each patient, the image data were pooled 
across i) all nuclei in a ﬁ  eld (2 assessments), and 
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ii) all nuclei for a patient (1 assessment) to yield a 
summary feature value [adjusted mean = mean/
(standard error of the mean)], for each of the 39 
image features for nuclei of the 3 different assess-
ments per patient: 2 ﬁ  elds, 1 overall. In addition, 
grading discriminant classiﬁ  cation functions, that 
are weighted combinations of image features, 
described below in the Analysis section, were 
assessed as prognostic factors.
Three different assessments, corresponding to 
the 3 different ways of pooling the image analysis 
feature data, were performed to examine the effects 
of DCIS heterogeneity on apparent associations 
with clinical outcome. In other contexts, investiga-
tions have been restricted to single ducts, ﬁ  elds, or 
pooled per person assessments without an exami-
nation of replicability.
Events
Recurrence of ipsilateral DCIS made more than 90 
days after the initial surgery was designated as an 
event. There were no developments of contralateral 
DCIS. There were no deaths from breast cancer, 
or another cause, in this group of patients over the 
study period.
Statistical analysis
Statistical analyses were performed with BMDP 
PC Dynamic Version 7.0 (same as BMDP-XP, 
Statistical Solutions, Sagua, MA, USA). Analy-
ses included for each image feature and each 
patient, 1) Levene’s tests for equality of variance 
between fields for each person and between 
people, 2) use of the mean/S.E.M. of image fea-
tures on a ﬁ  eld and patient basis due to highly 
signiﬁ  cant evidence against assumption of equal 
variances, 3) forward step-wise Fisher linear 
discriminant analyses, using an entry p-value of 
p = 0.05, and 4) jackknifed (leave-one-out) clas-
sification of patients to find the number of 
patients who were correctly classiﬁ  ed by the 
discriminant functions.
The histologic, clinical, and image analysis 
factors were assessed with respect to whether they 
were associated with ipsilateral DCIS recurrence. 
Univariate assessments were with Kaplan-Meier 
plots and the Wilcoxon (Peto-Prentice) test statis-
tic (Prentice and Marek, 1979); for each image 
feature, standard image analysis cut-points at the 
means of the data were utilized after conﬁ  rmation 
that the data were approximately symmetric.
Multivariate assessments utilized continuous data 
where possible, and were with Cox forward step-
wise regressions, using the likelihood ratio criterion 
(~χ
2
(1), p  0.05) as the test statistic to determine if 
a factor would be added to the model. Since we had 
no knowledge of which of the image analysis features 
assessed would best reﬂ  ect a patient's DCIS, or the 
extent to which differences in image features might 
relate to prognosis, we performed 3 sets of 
multivariate analyses, corresponding to the 3 gen-
erations of image feature factors per patient: per 2 
ﬁ  elds, 1 pooled across 2 ﬁ  elds.
Results
Suitability of H&E stained slides 
for image analysis
Archival H&E slides were satisfactory for image 
analysis for the majority of this DCIS cohort 
(Chapman et al. 2007). Only 5.7% (5/88) patients 
had slides that were of too poor quality.
Reproducibility of segmentation 
and image measurements
All nuclear regions of interest were segmented 
manually by the same operator (DA). Reproduc-
ibility of manual segmentation was determined by 
repeatedly segmenting the same nucleus (CV = 
3.4%, n = 150). In order to determine the reproduc-
ibility of extracted feature values, independent 
measurements were made of the same nucleus in 
images captured at different times. Ten or more 
nuclei, identiﬁ  ed from images of specimens of seven 
patients, were segmented at two different times 
without knowledge of the previously segmented 
region of interest, or of the extracted feature values. 
The differences between the pairs of measurements 
of the same nucleus were determined with a two-
tailed t-test. (The null hypothesis was that the dif-
ferences were equal to zero, df = n-1, at the 0.05 
level of signiﬁ  cance). The percent of feature values 
that were not statistically different in duplicate 
measurements ranged from 89.7% to 97.4% among 
nuclei of the seven patients. Further, there were no 
statistically signiﬁ  cant differences for 23 of the 39 
feature values in 7/7 pairs of images, and 37 of 39 
feature values in at least 5/7 pairs of images. Among 
the features whose values had minimal differences 
in all pairs of images there were two that were 
selected by discriminant analysis, the morphological 
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feature ellipse minor axis and the texture feature 
peak transition probability.
Classiﬁ  cation of patients by image 
analysis
In order to take into account patients with mixed 
grades, patients were classiﬁ  ed as deﬁ  ned above 
into Groups A, B, C, corresponding to low, inter-
mediate and high grades. These grading groups 
were used in discriminant analyses for nuclei in 
ﬁ  eld 1 (80 patients), ﬁ  eld 2 (79 patients), and over-
all pooled across both ﬁ  elds (80 patients). The 
results of the three discriminant analyses are pro-
vided in Table 1. In each instance (ﬁ  eld 1, ﬁ  eld 2, 
and overall across both ﬁ  elds), there were image 
features signiﬁ  cantly associated with the grading 
classiﬁ  cations, p  0.001 for each. The discrimi-
nant function for the ﬁ  rst ﬁ  eld included one mor-
phological feature reﬂ  ecting the size of nuclei 
(minor ellipse axis) and one texture feature reﬂ  ect-
ing the arrangement of DNA in the nucleus (sum 
entropy). Discriminant analysis of the second ﬁ  eld 
included one morphological feature (perimeter), 
one densitometric feature (range density) and one 
texture feature (angular second moment). The 
analyses for both ﬁ  elds indicated one morphomet-
ric feature (minor ellipse axis) and one texture 
feature (peak transition probability). Different 
image analysis features were obtained for the ﬁ  rst 
ﬁ  eld, second ﬁ  eld, and both ﬁ  elds. Correct clas-
siﬁ  cation of the nuclear grading with the image 
features for each ﬁ  eld was respectively, 65%, 
67.1% and 65.0%, in Table 1.
Discrimination using both ﬁ  elds would be most 
representative for a patient. A larger minor ellipse 
axis, indicative of a rounder nucleus, (p  0.001) 
and lower peak transition probability, indicating 
more uniform nuclear staining, (p  0.001) were 
associated with higher grading. Table 2 indicates 
the accuracy of image analysis classiﬁ  cation by 
nuclear grading group. Image analysis features 
correctly classiﬁ  ed 78.1% of patients in Group A 
(grade 1 and grade 2 nuclei), 48.4% in Group B 
(grade 2 and grade 3 nuclei), and 70.6% in Group 
C (grade 3 nuclei). The discriminant function was 
optimized to separate patients into the three nuclear 
grading groups. The distribution of patients within 
each of the three groups is illustrated in Figure 1. 
For each patient the canonical variable = 1.00475 
X (minor ellipse axis) – 0.60149 X (peak transition 
probability) – 1.7285, where the canonical variable 
has zero mean and coefﬁ  cients standardized by 
pooled within group variance, F-statistic = 12.304, 
df = 4,152, p  0.001. Although the discriminant 
function was optimized to provide the best classi-
ﬁ  cation of patients within the three grading groups, 
there was considerable overlap between patients in 
the three grading groups. Figure 2 shows the dis-
criminant function values ranked according to the 
value of the patient canonical variable; there is a 
nearly continuous distribution.
Table 3 indicates the factors significantly 
(p  0.05) associated with DCIS recurrence in the 
multivariate analyses based on data for the 2 ﬁ  elds 
and overall pooled assessments. Each model con-
tains both clinical and image features; however, 
the image features differ. The overall pooled data 
would represent the best available summary for 
the patients. The factors signiﬁ  cantly associated 
with recurrence of DCIS, were those previously 
found by Miller et al. 2001, type of initial 
presentation (p = 0.03), and amount of parenchy-
mal involvement (p = 0.05), along with the 
Table 1. Image features discriminating grading groups.
Field




Field 1 Morphologic: minor ellipse axis 0.001 65.0%
Texture: sum entropy
Field 2 Morphologic: perimeter 0.001 67.1%
Texture: angular second moment
Densitometric: range density
Both ﬁ  elds Morphometric: minor ellipse axis 0.001 65.0%
Texture: peak transition probability
aField 1 and Field 2 each had 5 different ducts. 
bp-values are based on F-statistic of ﬁ  nal discriminant models. 
cJackknifed (leave-one-
out) classiﬁ  cation.
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morphometry image feature ellipticity, p = 0.04. 
Figure 3 shows the Kaplan-Meier plot for the 
image feature; smaller ellipticity (less elongated 
and more rounded nuclei) was associated with 
higher DCIS recurrence Van Nuys nuclear grade, 
predominant grade, and the grading discriminant 
function were not signiﬁ  cantly associated with 
recurrence of ipsilateral DCIS.
Discussion
Nuclear grade, or all grades when there was more 
than one grade, was reported for each patient by 
the pathologist according to the Van Nuys system 
(Holland et al. 1994; Silverstein et al. 1995). This 
system has been compared to other systems that 
have been proposed to predict development of 
inﬁ  ltrating carcinoma (Badve et al. 1998; Leong 
et al. 2001; Douglas-Jones et al. 1996). Several of 
these grading systems have recently been reviewed 
(Leonard and Swain, 2004). The greatest consis-
tency among pathologists seems to be obtained 
with systems that are based, in large part, on 
nuclear grade (Morrow et al. 2002) and a consen-
sus conference on classiﬁ  cation of DCIS recom-
mended that DCIS should be stratiﬁ  ed primarily 
by nuclear grade (Schwartz, 1997). Our results 
indicate that image analysis can provide a repro-
ducible quantitative description of nuclei for this 
purpose since duplicate measurements were simi-
lar for 89.7% to 97.4% of features assessed.
We investigated the ability of 39 image features 
describing nuclear morphology (size and shape), 
densitometry (amount of stain), and texture 
(arrangement of DNA) to quantitatively discrimi-
nate tumors with pathologically determined nuclear 
grade. The most representative grading for a patient 
utilized data obtained for nuclei in both ﬁ  elds. 
Features included in the discriminant function were 
one whose value was determined by the size and 
shape of the nuclei (minor ellipse axis) and one 
whose value was determined by the arrangement 
of DNA in the nuclei (peak transition probability). 
Similar rates of accurate classiﬁ  cation of grade 
were obtained from the ﬁ  rst ﬁ  eld assessed (about 
100 nuclei), the second ﬁ  eld (about 100 nuclei), 
and both ﬁ  elds (about 200 nuclei), with correct 
classiﬁ  cations of respectively 65.0%, 67.1%, and 
65.0% of the patients. However, the discriminant 
functions for the three situations differed by image 
features. Discrimination using both ﬁ  elds would 
be the most representative of the patient’s 
grading.
Discriminant analysis has frequently been used 
to classify patients based on feature values deter-
mined by computer-aided image cytometry (Baak 
et al. 1991; Bartels, 1980; Patterson, 1995). The 
features selected and the weights assigned to each 
feature are readily interpretable. Further, we exam-
ined the relevance of the continuous discriminant 
functions here in a censored survival analysis 
framework.
In this study, image features were extracted 
from H&E stained slides rather than Feulgen 
stained slides. The Feulgen reaction is useful 
because it is speciﬁ  c for DNA, the intensity of the 
reaction is proportional to the amount of DNA, 
and nuclear regions of interest can be automati-
cally segmented (Schulte et al. 1995). However, 
conventional H&E stained slides have also been 
used to extract morphometric and other nuclear 
feature values (Frank et al. 2001; Tuczek et al. 
1996; Wolberg et al. 1995; Christen et al. 1993; 
Peinta and Coffey, 1991; Weyn et al. 2000). The 
possibility of extracting nuclear features from 
H&E stained slides offers several advantages. 
First, existing H&E stained slides available from 
Table 2. Classiﬁ  cation of groups with image features.
Group Patients in group Number of patients 




A 32 25 4 3 78.1
B 31 8 15 8 48.4
C 17 0 5 12 70.6
Total 80 33 24 23 65.0
Notes: Classiﬁ  cation is based on about 200 nuclei per patient in two ﬁ  elds. Jackknifed (leave-one-out) assessment of classiﬁ  cation was 
used.
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pathology archives can be used without recovering 
the original paraffin blocks, recutting tissue 
sections, and staining the new slides with the 
Feulgen procedure; second, digital images of each 
microscopic ﬁ  eld can be acquired by the image 
analysis system simultaneously with review by a 
pathologist viewing familiar H&E stained tissue. 
Although the density measurements extracted 
from H&E stained slides are not directly 
proportional to amount of DNA as they are for 
Feulgen stain, we have found that nuclear area is 
proportional to amount of DNA as determined by 
Feulgen (r = 0.886). Nevertheless, measurement 
of nuclear area in H&E stained specimens is not 
an adequate substitute for measurement of DNA 
ploidy as determined with the DNA-speciﬁ  c Feul-
gen stain. In the future, the labor intensive chore 
of manually segmenting nuclear regions of H&E 
stained slides might be overcome by acquiring 
color images and segmenting them with appropri-
ate algorithms (Ferr-Roca et al. 1998; Latson et al. 
2003). In our study only 5.7% of the archival slides 
had too poor stain quality for image analysis.
Patients with breast DCIS that had intermediate 
nuclear grades, and/or more than one grade, offer 
challenges to pathologists. Such patients may rep-
resent as much as 50% of DCIS patients (Miller 
et al. 2001). In this study computer-aided image 
analysis was used to assess a cohort of patients 
who presented with DCIS, many with intermediate 
or mixed grades. H&E stained slides were viewed 
by a pathologist who recorded the nuclear grades 
in each ﬁ  eld and digital images were acquired 
simultaneously. Nuclear image feature values were 
extracted and patients classiﬁ  ed by discriminant 
analysis using the pathologist’s grouping of 
patients to supervise the analysis. Patients were 
placed into three groups according to the grades 
assigned by the pathologist taking into account the 
large proportion of patients with intermediate 
and/or mixed grades. The discriminant function 
correctly classify 78.1% of patients with low 
nuclear grade, and 70.6% of patients with high 
nuclear grade. The same discriminant function had 
Figure 1. Distribution of patients between groups. a, Group A; b, 
Group B; c, Group C. The value of the discriminant function for each 
patient is determined by a weighted combination of image features 
signiﬁ  cantly associated (p  0.001) with the characteristics of the 
grading groups. Factors that dealt with a larger minor ellipse axis, 
indicative of a rounder nucleus, (p  0.001) and lower peak transition 
probability, indicating more uniform nuclear staining, (p  0.001) 
were associated with higher grading.
Figure 2. Distribution of all patients by rank according to the value 
of their canonical variable. There is a nearly continuous distribution 
of patients.
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a poorer success rate of only 48.4% for the 
intermediate group. This suggests that the 
intermediate group could be subtyped by 
characteristics different than those separating the 
low and high grade groups. Such subtypes of the 
intermediate grade group might be relevant for 
therapeutic decisions.
Since high nuclear grade is one of the factors 
that has been associated with recurrence it might 
be expected that high nuclear grade would also be 
associated with recurrence within this cohort of 
patients. However, neither the highest nuclear 
grade, nor the most prominent nuclear grade, was 
associated with recurrence (Miller et al. 2001; 
Table 3. Clinical, histologic, and image analysis factors affecting DCIS recurrence by image analysis 
assessment.




Texture (Histogram mean)  0.01  Densitometry (Range density)  0.001
Initial presentation  0.01  Measured margin  0.001
Parenchymal involvement  0.02  Densitometry (Sum density)  0.02
Architecture  0.05  Van Nuys Prognostic Index  0.04
 Both  ﬁ  elds – Overall   
 Morphometry  (Ellipticity)  p  = 0.04 
 Initial  presentation  p  = 0.03 
 Parenchymal  involvement  p  = 0.05 
aFactors signiﬁ  cantly (p  0.05) associated with DCIS recurrence, in the order entered into the step-wise forward Cox regression models.
Figure 3. Kaplan-Meier plot of image feature signiﬁ  cantly associated with recurrence of DCIS: Morphometry (ellipticity), p = 0.04. The recur-
rence rates at 5 years are 25% for patients with Ellipticity less than or equal to the mean, and 17% for those with Ellipticity greater than the 
mean; the numbers of patients remaining at risk at 5 years are respectively, 23 and 24.
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Chapman et al. 2007). The large proportion of 
patients with mixed nuclear grades may have 
contributed to the lack of association. In order to 
take into account the patients with mixed grades, 
discriminant analysis used the pathologist’s 
nuclear grade(s) for each patient, the grouping of 
patients with mixed grades, and the quantitative 
nuclear feature values determined by image 
cytometry. A discriminant function was derived 
that optimized the classiﬁ  cation of patients into 
grading groups. The value of the canonical vari-
able was determined for each patient. The canon-
ical variable was standardized across patient 
values to have a mean of zero and a standard 
deviation of one. The distribution of patient values 
by canonical variable appeared to be continuous 
rather than three discrete and separate groups. The 
discriminant function was not associated with 
ipsilateral DCIS recurrence, although it had been 
with some pooled assessments concerning the 
development of invasive breast cancer (Chapman 
et al. 2007). One of the image features included 
in the discriminant function was minor ellipse axis 
(p  0.001); it is noteworthy that a related feature, 
ellipticity, was associated with DCIS recurrence 
(p = 0.04). Rounder nuclei were associated both 
with higher grade and DCIS recurrence. It should 
be noted that this association was found with 
image feature adjusted means, after accounting 
for the greater variability observed with high 
nuclear grade. The image features alone would 
not be expected to be sufﬁ  cient for prognosis. 
However, the additional information, added to 
other pathologic and molecular features, may 
improve the prognostic classiﬁ  cation of patients.
Conclusion
A discriminant function was derived that optimized 
the classiﬁ  cation of DCIS patients with mixed 
nuclear grades. The classiﬁ  cation of patients into 
grading groups was significant (p  0.001), 
although the separation of patient grading groups 
was not complete. Grouping patients with mixed 
nuclear grades and measuring their nuclear image 
features may contribute to their classiﬁ  cation and 
prognosis.
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A custom image cytometry system was assembled 
which consisted of a CCD camera attached to a 
bright ﬁ  eld microscope and linked to a desktop 
computer with a frame grabber card. Images of 
nuclei were acquired and stored as follows: 
hematoxylin and eosin stained slides were viewed 
with a bright ﬁ  eld microscope (Wild model M20), 
40X N.A. 0.75 objective, 1.25X phototube, 
530–590 nm band pass green ﬁ  lter, detected with 
an 8 bit monochrome CCD camera (Sonyo model 
VDC3874) connected to a video monitor (RCA 
TC1112) and a frame grabber card (60 HZ Data 
Translation Quick Capture model DT2255) in a 
desktop computer (Apple Macintosh model IIci, 
12 MB RAM, 80 MB hard disk), and stored as 
uncompressed TIFF ﬁ  les on removable media 
(Zip 100 disks). Ten frames were averaged and 
acquired using NIH-Image software (v. 1.57, writ-
ten by Wayne Rasband, obtained from the internet 
by anonymous FTP). Each TIFF formatted image 
was 640 × 480 pixels, with 256 gray levels. 
The resulting pixel images were isotropic, with an 
effective size of 0.25 microns × 0.25 microns. 
Segregated nuclear images were of modest resolu-
tion, typically containing 800 to 1600 square 
pixels. Sizes were calibrated with a B&L stage 
micrometer. Optical density of pixel gray values 
was standardized and camera response calibrated 
with a set of neutral density ﬁ  lters (50, 25, and 
12.5% transmission).
Software
NIH-Image v.1.62b34-Arnv software (modiﬁ  ed 
from http://rsb.info.nih.gov/) and StatView 
v. 5.01 statistical package (BrainPower, Calabasas, 
CA, USA) were used to measure and calculate 
DNA densitometric and nuclear morphometric 
features using a Mac G4 computer. TextureCalc 
v. 1.1ax, software (written by W. C.-B.) was used 
to rebin 256 gray levels into 8 intervals and to 
calculate texture features from the Markovian 
gray level co-occurrence matrices. Programs 
written in SAS release 6.12 for the Macintosh 
(SAS Institute, Inc., Cary, NC, USA) were used 
to format data and BMDP PC Dynamic Version 
7.0 (Statistical Solutions, Sagua, MA, USA) 
statistical software was used for discriminant 
analysis.
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